CXSB2101019 | IBI110 | IBI110 | Other | Biological Products(1) | Supplementary Application | 2021-06-17 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL2101127 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2021-06-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL2101126 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2021-06-17 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL2101406 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2021-11-02 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL2200397 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2022-08-23 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL2101516 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2021-12-30 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXSL1900040 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2019-04-26 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-04-25 | view |